research use only
Cat.No.S8980
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other NAMPT Inhibitors | OT-82 Padnarsertib (KPT-9274, ATG-019) GMX1778 STF-118804 P7C3 GNE-617 |
|
In vitro |
DMSO
: 80 mg/mL
(198.77 mM)
Ethanol : 2.5 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 402.47 | Formula | C19H22N4O4S |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 2237268-08-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CC2CN(CC1O2)S(=O)(=O)C3=CC=C(C=C3)NC(=O)NCC4=CC=NC=C4 | ||
| Targets/IC50/Ki |
NAMPT
|
|---|---|
| In vitro |
SBI-797812 shifts the NAMPT reaction equilibrium towards nicotinamide mononucleotide formation, increases NAMPT affinity for ATP, stabilizes phosphorylated NAMPT at His247, promotes consumption of the pyrophosphate by-product, and blunts feedback inhibition by NAD+. Treatment of cultured cells with this compound increases intracellular nicotinamide mononucleotide and NAD+. |
| In vivo |
Plasma concentrations of SBI-797812 after oral administration are low. Higher plasma levels of this compound are seen after i.p. dosing. The potency of this chemical against mouse NAMPT is investigated. The apparent affinity (EC50) of this agent for mouse NAMPT is approximately 8-fold less than for human NAMPT, whereas maximal fold activation by this compound is comparable between the mouse and human NAMPT. Dosing of mice with this chemical elevates liver NAD+. |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.